4//SEC Filing
Jenne Kyle 4
Accession 0000874015-25-000027
CIK 0000874015other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:55 PM ET
Size
5.7 KB
Accession
0000874015-25-000027
Insider Transaction Report
Form 4
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-01-02+18,700→ 18,700 totalExercise: $34.69From: 2026-01-02Exp: 2035-01-01→ Common Stock (18,700 underlying)
Footnotes (1)
- [F1]Grant on 01/02/2025 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2020 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2025. 25% of the shares subject to the option will vest and become exercisable on 01/02/2026. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001791857
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:55 PM ET
- Size
- 5.7 KB